期刊文献+

结核病疫苗研究进展 被引量:7

下载PDF
导出
出处 《中国生物制品学杂志》 CAS CSCD 2001年第3期186-187,共2页 Chinese Journal of Biologicals
  • 相关文献

参考文献3

  • 1De Lislegw,Infect Immun,1999年,67卷,2624页
  • 2Li Z M,Infection and Immunity,1999年,67卷,4780页
  • 3Zhu X,Immumology,1997年,92卷,6页

同被引文献42

  • 1何炬斌.白细胞介素─2在结核病治疗中的应用[J].上海免疫学杂志,1994,14(4):245-246. 被引量:2
  • 2Fine PEM.Variation in protection by BCG:implications of and for heterologous immunity[J].Lancet,1995,346:1339-1345.
  • 3Harboe M,Oettinger T,Wiker HG,et al.Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG[J].Infect Immun,1996,64:16-22.
  • 4萨姆布鲁克 J,弗里奇 E F,曼尼阿蒂斯 T.分子克隆[M].2版.北京:科学出版社,1992:28.
  • 5Lowrie DB,Silva CL,Tascon RE,et al.Genetic vaccination against tuberculosis[J].Springer Semin Immunopathol,1997,19:161.
  • 6Arend SM.,Geluk A,Meijgaarden KE,et al.Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides[J].Infect Immun,2000,68:3314-3321.
  • 7Brandt L,Elhay M,Rosenkrands I,et al.ESAT-6 subunit vaccination against Mycobacterium tuberculosis[J].Infect Immun,2000,68:791-795.
  • 8[1]Fine P E M.Variation in protection by BCG:implications of and for heterologous immunity.Lancet,1995;346(8986):1339-1345
  • 9[2]Shinnick T M.The 65-kilodalton antigen of Mycobacterium tuberculosis.J Bacteriol,1987;169(3):1080-1088
  • 10[3]Kaufmann S H,Vath U,Thole J E,et al.Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kD protein.Eur J Immunol,1987,17(3):351-357

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部